Access to primary care and mortality in excess for patients with cancer in France: Results from 21 French Cancer Registries

Author:

Gardy Joséphine1234ORCID,Wilson Sarah2,Guizard Anne‐Valérie14,Bouvier Véronique123,Launay Ludivine2,Alves Arnaud123,Bara Simona15,Bouvier Anne‐Marie16789ORCID,Coureau Gaëlle1101112,Cowppli‐Bony Anne1131415,Dabakuyo Yonli Sandrine116ORCID,Daubisse‐Marliac Laëtitia1171819,Defossez Gautier12021,Hammas Karima122,Hure Florent123,Jooste Valérie16789,Lapotre‐Ledoux Bénédicte12425,Nousbaum Jean‐Baptiste1262728,Plouvier Sandrine129,Seigneurin Arnaud130,Tretarre Brigitte11831,Vigneron Nicolas14,Woronoff Anne‐Sophie132,Launoy Guy2,Molinie Florence1131415,Bryere Joséphine2,Dejardin Olivier233

Affiliation:

1. FRANCIM Network Toulouse France

2. ANTICIPE U1086 INSERM‐UCN Caen France

3. Calvados Digestive Cancer Registry University Hospital of Caen Caen France

4. Calvados General Tumor Registry Centre François Baclesse Caen France

5. Manche Cancer Registry Cherbourg‐en‐Cotentin France

6. Digestive Cancer Registry of Burgundy Dijon France

7. Dijon University Hospital Dijon France

8. NSERM UMR 1231 I Dijon France

9. University of Burgundy Dijon France

10. University of Bordeaux Gironde General Cancer Registry Bordeaux France

11. Inserm Bordeaux Population Health Research Center U1219 Team EPICENE Bordeaux France

12. CHU Bordeaux Bordeaux France

13. Loire‐Atlantique/Vendée Cancer Registry Nantes France

14. SIRIC ILIAD INCa‐DGOS‐Inserm_12558 CHU Nantes Nantes France

15. CERPOP UMR 1295 Université de Toulouse III Toulouse France

16. National Quality of Life and Cancer Clinical Research Platform Georges François Leclerc Cancer Center ‐UNICANCER Dijon France

17. Tarn Cancer Registry Claudius Regaud Oncopole IUCT‐O Toulouse France

18. CERPOP INSERM U1295 Toulouse III University Toulouse France

19. Toulouse University Hospital Toulouse France

20. Poitou‐Charentes General Cancer Registry CHU de Poitiers Poitiers France

21. CIC‐1402 INSERM Université de Poitiers Poitiers France

22. Haut‐Rhin Cancer Registry Groupe hospitalier de la région de Mulhouse et Sud‐Alsace (GHRMSA) Mulhouse France

23. Haute‐Vienne General Cancer Registry CHU Limoges Limoges France

24. Somme Cancer Registry CHU Amiens‐Picardie Amiens France

25. CHIMERE (Chirurgie, imagerie et régénération tissulaire de l’extrémité céphalique – Caractérisation morphologique et fonctionnelle) UR UPJV Amiens France

26. Digestive Tumor Registry of Finistère Brest University Hospital Brest France

27. EA 7479 SPURBO Brest University Hospital Brest France

28. Hepato‐Gastroenterology Department University Hospital Brest France

29. Lille Area General Cancer Registry GCS‐C2RC Alliance Cancer Lille France

30. Isère Cancer Registry CHU Grenoble Alpes Pavillon E – BP 217 Grenoble CEDEX 9 France

31. Hérault Cancer Registry Montpellier France

32. Doubs Cancer Registry University hospital Besançon Besançon France

33. Epidemiology Research and Evaluation Unit Department of Research University Hospital of Caen Caen France

Abstract

ABSTRACTBackgroundThe impact of geographical accessibility on cancer survival has been investigated in few studies, with most research focusing on access to reference care centers, using overall mortality and limited to specific cancer sites. This study aims to examine the association of access to primary care with mortality in excess of patients with the 10 most frequent cancers in France, while controlling for socioeconomic deprivation.MethodsThis study included a total of 151,984 cases diagnosed with the 10 most common cancer sites in 21 French cancer registries between 2013 and 2015. Access to primary care was estimated using two indexes: the Accessibilité Potentielle Localisée index (access to general practitioners) and the Scale index (access to a range of primary care clinicians). Mortality in excess was modelized using an additive framework based on expected mortality based on lifetables and observed mortality.FindingsPatients living in areas with less access to primary care had a greater mortality in excess for some very common cancer sites like breast (women), lung (men), liver (men and women), and colorectal cancer (men), representing 46% of patients diagnosed in our sample. The maximum effect was found for breast cancer; the excess hazard ratio was estimated to be 1.69 (95% CI, 1.20–2.38) 1 year after diagnosis and 2.26 (95% CI, 1.07–4.80) 5 years after diagnosis.InterpretationThis study revealed that this differential access to primary care was associated with mortality in excess for patients with cancer and should become a priority for health policymakers to reduce these inequalities in health care accessibility.

Funder

Ligue Contre le Cancer

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3